Seminars in Immunology

Papers
(The median citation count of Seminars in Immunology is 11. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)
ArticleCitations
Exploiting antifungal immunity in the clinical context322
Editorial Board93
Cellular stress and macrophage activation92
Differential immune responses behind different celiac disease manifestations80
Myeloid derived suppressor cells in tumor microenvironment: Interaction with innate lymphoid cells79
Editorial Board76
Accumulation of immune-suppressive CD4 + T cells in aging – tempering inflammaging at the expense of immunity76
Three’s company: The cooperative signals behind the differentiation of Th9 cells76
Microbial metabolites and immunotherapy: Basic rationale and clinical indications67
Pyroptosis modulation by bacterial effector proteins64
Aging of lymphoid stromal architecture impacts immune responses59
They shall not grow mold: Soldiers of innate and adaptive immunity to fungi58
NGS data analysis for molecular diagnosis of Inborn Errors of Immunity54
Oncolytic virus-mediated immunomodulation in glioblastoma: Insights from clinical trials and challenges53
Local and Cell-intrinsic complement: The new player in cancer progression51
Immunity to pathogenic fungi in the eye45
Immunoglobulins at the interface of the gut mycobiota and anti-fungal immunity44
Therapeutic immune tolerance for central nervous system autoimmune diseases – Prospects, challenges and pitfalls43
Seminars in immunology special issue: Nutrition, microbiota and immunity The unexplored microbes in health and disease42
IL-1 family members as regulators of lymphoid type-2 immunity in cancer42
The noncanonical inflammasome-induced pyroptosis and septic shock39
Pyroptosis: A road to next-generation cancer immunotherapy39
Pyroptosis and the cellular consequences of gasdermin pores38
Different routes of MHC-I delivery to phagosomes and their consequences to CD8 T cell immunity38
Interplay between the complement system and other immune pathways in the tumor microenvironment36
Western diet influences on microbiome and carcinogenesis35
Autoimmune diabetes and targets for immunomodulation32
Immunity to fungi: Editorial overview32
Beyond the Norm: The emerging interplay of complement system and extracellular matrix in the tumor microenvironment32
The paradox of aging: Aging-related shifts in T cell function and metabolism31
TREM2: A new player in the tumor microenvironment31
Neuroimmune interactions between itch neurons and skin microbes31
Adaptive NK cell response to human cytomegalovirus: Facts and open issues31
Interleukin-1β and cancer immune response29
Antigen discovery for the development of cancer immunotherapy28
The evolving biology of cross-presentation28
Thymus aging and immune reconstitution, progresses and challenges27
Sialic acid and Siglec receptors in tumor immunity and immunotherapy26
Annexin A1 based inflammation resolving mediators and nanomedicines for inflammatory bowel disease therapy25
Diverse IL-9-secreting T helper cells direct responses in the allergic lung25
Resolution pharmacology − A fresh approach to the clinical management of human inflammatory diseases25
Introduction to the Special Issue: Nutrition, microbiota and immunity25
Individual- and population-associated heterogeneity in vaccine-induced immune responses. The impact of inflammatory status and diabetic comorbidity24
Age-dependent changes in T follicular helper cells shape the humoral immune response to vaccination24
The tissue glycome as regulator of immune activation and tolerance mediated by C-type lectins and Siglecs24
T cell control of SARS-CoV-2: When, which, and where?24
What fungal CNS infections can teach us about neuroimmunology and CNS-specific immunity23
The immunological processes behind aquaporin 4-antibody seropositive neuromyelitis optica spectrum disorders23
T cell fate decisions during memory cell generation with aging23
Activation of B cells in Tertiary Lymphoid Structures in cancer: Anti-tumor or anti-self?22
Antigen cross-presentation by dendritic cells: A critical axis in cancer immunotherapy22
Editorial Board22
Epithelial inflammasomes, gasdermins, and mucosal inflammation – Lessons from Salmonella and Shigella infected mice21
Immunotherapy targeting inhibitory checkpoints: The role of NK and other innate lymphoid cells21
Regulation of innate immune system function by the microbiome: Consequences for tumor immunity and cancer immunotherapy21
The glycoimmune landscape in health and disease21
Proteostasis in T cell aging21
Better safe than sorry: Naive T-cell dynamics in healthy ageing20
The complement system in clinical oncology: Applications, limitations and challenges20
Human thymus in health and disease: Recent advances in diagnosis and biology19
Disorganization of secondary lymphoid organs and dyscoordination of chemokine secretion as key contributors to immune aging18
Global aspects of celiac disease and food allergy18
The multisensory regulation of unconventional T cell homeostasis18
Harnessing complement biomarkers for precision cancer care18
The role of non-cancer cell infections in oncolytic virus therapy17
A major mechanism for immunomodulation: Dietary fibres and acid metabolites17
To kill or not to kill – The role of the tumor microenvironment in shaping group 1 ILC functions17
Unconventional protein secretion by gasdermin pores17
Epigenetic and transcriptional control of gasdermins17
New insights into Th9 cells in inflammatory bowel diseases17
T follicular helper cells in cancer, tertiary lymphoid structures, and beyond17
Complement regulators as novel targets for anti-cancer therapy: A comprehensive review17
Editorial Board16
Unraveling the pathophysiology of narcolepsy type 1 through hypothesis-driven and hypothesis-generating approaches16
Siglecs as modulators of macrophage phenotype and function16
Development of synthetic lipoxin-A4 mimetics (sLXms): New avenues in the treatment of cardio-metabolic diseases16
Editorial: Autoimmune diseases of the central nervous system16
Tumor associated macrophage in HPV+ tumors: Between immunosuppression and inflammation16
Microbial gasdermins: More than a billion years of pyroptotic-like cell death16
Systems analysis of innate and adaptive immunity in Long COVID15
Pyroptosis-induced inflammation and tissue damage15
IL-1R8: A molecular brake of anti-tumor and anti-viral activity of NK cells and ILC15
Durability of immune responses to SARS-CoV-2 infection and vaccination15
Editorial Board14
The role of ILC subsets in cancer14
Impact of dietary carbohydrate restriction on the pathobiology of Hepatocellular Carcinoma: The gut-liver axis and beyond14
Galectins and Host–Pathogen Interactions: The roles in viral infections14
Integrating immunopeptidome analysis for the design and development of cancer vaccines14
The gut-brain vascular axis in neuroinflammation13
Variable domain glycosylation as a marker and modulator of immune responses: Insights into autoimmunity and B-cell malignancies13
Numbers and odds: TCR repertoire size and its age changes impacting on T cell functions13
Systems analysis of human innate immunity in COVID-1913
Complement regulation in tumor immune evasion13
Introduction to the Special Issue: Pyroptosis in Immunity and Inflammation13
Regulatory T cells in allergic inflammation13
Endogenous glucocorticoids and human immunity: Time to revisit old dogmas13
Somatic mosaicism in inborn errors of immunity: Current knowledge, challenges, and future perspectives12
Chemical modulation of gasdermin D activity: Therapeutic implications and consequences12
Editorial Board12
The spatial and single-cell landscape of skin: Charting the multiscale regulation of skin immune function12
To die or not to die: Gasdermins in intestinal health and disease11
Inflammation-mediated tissue damage in pulmonary tuberculosis and host-directed therapeutic strategies11
Uncovered role of Th9 and IL-9 in rheumatoid arthritis: Current status and future directions11
Immunity to fungi in the lung11
Latest insights into oncolytic viro-immunotherapy with vesicular stomatitis virus11
Aging unconventionally: γδ T cells, iNKT cells, and MAIT cells in aging11
The role of sialoglycans in modulating dendritic cell function and tumour immunity11
Beyond youth: Understanding CAR T cell fitness in the context of immunological aging11
0.16598010063171